Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Table 5

Scores in each visit for token test (scores presented as mean of the scores in the test [SD] values).

Token test	Amisulpride	Olanzapine
Visit 1	14.18 [3.37]	14.34 [3.64]
Visit 2	18.81 [3.22]	17.78 [3.37]
Visit 3	22.40 [3.21]	21.12 [3.45]
Mean change	8.26 [1.56]	6.78 [2.09]